Results 211 to 220 of about 50,358 (293)
Cecal Leiomyosarcoma Management: A Case Report and Review of Literature. [PDF]
Canaan LN, Lahart EN, Sarmiento D.
europepmc +1 more source
Paratesticular sarcoma of the spermatic cord: A rare case of dedifferentiated leiomyosarcoma. [PDF]
Çi̇çek R +5 more
europepmc +1 more source
Identification of Key Genes via Integrated Multi-Omics and Machine Learning Uncovers Tumor Biological Features and Prognostic Biomarkers in Uterine Leiomyosarcoma. [PDF]
Lu W +8 more
europepmc +1 more source
Benign Nodular Smooth Muscle Proliferation of the Lung Mimicking Malignancy. [PDF]
Bečejac T +3 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Hematology/Oncology Clinics of North America, 2013
This article presents an overview of the current literature about the biology, pathology, and the clinical management of leiomyosarcoma. In addition, the article emphasizes and discusses the current systemic treatment options available for patients with leiomyosarcoma, which range from cytotoxic chemotherapy to target therapies.
Suzanne George
exaly +3 more sources
This article presents an overview of the current literature about the biology, pathology, and the clinical management of leiomyosarcoma. In addition, the article emphasizes and discusses the current systemic treatment options available for patients with leiomyosarcoma, which range from cytotoxic chemotherapy to target therapies.
Suzanne George
exaly +3 more sources
Leiomyosarcoma of the Larynx [PDF]
Leiomyosarcoma involving the larynx is extremely rare and may be difficult to diagnose. Because of the rarity of this tumor, little information exists on its long-term follow-up and optimal management. We present a review of the literature and report on a patient with leiomyosarcoma of the larynx treated with surgery and postoperative irradiation.
Andrea Luigi Cavalot +4 more
openaire +3 more sources
Uterine leiomyosarcoma is a rare and heterogeneous gynecological malignancy that poses a significant clinical challenge due to its aggressive nature and limited treatment options. Its multifactorial etiopathogenesis involves complex cytogenetic and molecular aberrations, including TP53, RB1, and chromothripsis-associated gene alterations.
Giorgio Bogani +39 more
openaire +5 more sources

